Morton Plant Hospital Association, INC.

Morton Plant Hospital Association, INC. was paid $15.79M by Medicaid between Jan 2018 and Dec 2024, across 309 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.

33Billing provider infoMORTON PLANT HOSPITAL ASSOCIATION, INC.
CLEARWATER, FL 33756

33aNPI1235371378assigned 04/06/2009

33bProvider typePsychiatric Hospital Unit

28Total paid$15.79M

24GClaims1,133,805

24DCodes billed309

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Psychiatric Hospital Unit providers in Florida

Rank by total paid#3 of 15

Median peer was paid$7.13M

This provider vs. median2.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	117,638	$817K
2019	246,924	$2.87M
2020	238,721	$2.72M
2021	242,900	$3.36M
2022	196,534	$3.58M
2023	68,649	$1.70M
2024incomplete	22,439	$746K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	17%	33,384	29,715	$2.74M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	15%	39,221	31,281	$2.31M
80053	Comprehensive metabolic panel	5.6%	50,979	37,040	$885K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.4%	18,634	14,227	$849K
70450	Computed tomography, head or brain; without contrast material	3.9%	10,183	7,795	$619K
74177	Computed tomography, abdomen and pelvis; with contrast material	3.7%	5,212	4,422	$588K
36415	Collection of venous blood by venipuncture	3.1%	80,717	53,994	$491K
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.7%	5,363	4,802	$419K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	2.5%	11,007	8,009	$399K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	2.4%	8,740	6,955	$380K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	2.3%	3,590	1,004	$358K
80048	Basic metabolic panel (calcium, ionized)	2.2%	24,753	16,544	$353K

297 more codes

97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.2%	8,170	$345K
81003		1.5%	34,483	$238K
74176	Computed tomography, abdomen and pelvis; without contrast material	1.4%	2,205	$225K
59899		1.2%	3,105	$192K
C1729	Catheter, drainage	1.2%	647	$185K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.1%	2,102	$173K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,448	$150K
G0378	Hospital observation service, per hour	<1%	18,166	$143K
87631		<1%	3,587	$143K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	3,074	$131K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,357	$114K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	7,210	$113K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	2,728	$109K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	8,427	$101K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	1,301	$97K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	8,440	$93K
81025		<1%	4,069	$92K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,036	$90K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,827	$90K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	5,140	$90K
82948		<1%	16,981	$89K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,438	$89K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	3,727	$78K
96367		<1%	2,063	$73K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	7,900	$69K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,177	$69K
96361	Intravenous infusion, hydration; each additional hour	<1%	1,221	$63K
80047		<1%	15,752	$58K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	2,861	$57K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	83,609	$56K
84484		<1%	25,399	$54K
76819	Fetal biophysical profile; without non-stress testing	<1%	756	$53K
J7050	Infusion, normal saline solution, 250 cc	<1%	2,585	$50K
87086	Culture, bacterial; quantitative colony count, urine	<1%	14,931	$46K
84443	Thyroid stimulating hormone (TSH)	<1%	16,978	$38K
84702		<1%	4,685	$36K
73610		<1%	1,285	$36K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	2,573	$36K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	5,856	$34K
97162		<1%	745	$33K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,836	$33K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	1,752	$32K
87070		<1%	3,036	$31K
87480		<1%	5,371	$31K
73562		<1%	1,932	$30K
73630		<1%	1,601	$29K
70486		<1%	769	$27K
73110		<1%	883	$27K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	29,376	$27K
73130		<1%	1,130	$27K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,632	$26K
71046	Radiologic examination, chest; 2 views	<1%	7,278	$26K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	3,607	$25K
97163		<1%	1,398	$25K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	4,625	$25K
36591		<1%	1,573	$24K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	5,622	$23K
C1769	Guide wire	<1%	1,210	$22K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	862	$21K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	13,458	$21K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,116	$20K
71045	Radiologic examination, chest; single view	<1%	14,282	$20K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	56	$20K
73030		<1%	1,507	$19K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	3,159	$19K
96375	Therapeutic injection; each additional sequential IV push	<1%	2,686	$18K
83735		<1%	13,566	$17K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,277	$17K
72040		<1%	1,597	$16K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	908	$16K
85660		<1%	576	$15K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,203	$15K
85610		<1%	14,549	$15K
72100		<1%	2,534	$15K
97116		<1%	833	$14K
87641		<1%	2,454	$14K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	3,689	$14K
93971		<1%	1,538	$13K
83880		<1%	11,166	$13K
80076		<1%	4,277	$13K
80061	Lipid panel	<1%	15,432	$13K
85027		<1%	12,114	$13K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	8,452	$12K
A9270	Non-covered item or service	<1%	6,216	$12K
73140		<1%	237	$12K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	260	$12K
86780		<1%	1,584	$12K
49083		<1%	369	$11K
73080		<1%	389	$11K
11043		<1%	475	$11K
86140		<1%	3,817	$10K
85652		<1%	3,274	$10K
83036	Hemoglobin; glycosylated (A1C)	<1%	12,362	$10K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	7,913	$9K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	169	$9K
87186		<1%	6,507	$8K
J0690	Injection, cefazolin sodium, 500 mg	<1%	2,336	$8K
74022		<1%	1,555	$8K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	1,532	$8K
87077		<1%	7,601	$8K
86850		<1%	4,283	$8K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	89	$8K
97014		<1%	109	$7K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	552	$7K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	389	$6K
83970		<1%	1,225	$6K
76801		<1%	2,115	$6K
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	16,590	$6K
J1644	Injection, heparin sodium, per 1000 units	<1%	1,064	$6K
74018		<1%	719	$6K
85730		<1%	6,135	$5K
J3480	Injection, potassium chloride, per 2 meq	<1%	192	$5K
73502		<1%	826	$5K
84703		<1%	8,695	$5K
86900		<1%	4,696	$5K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	570	$5K
82247		<1%	1,368	$5K
86803		<1%	2,433	$5K
84145		<1%	3,612	$5K
84100		<1%	2,696	$5K
87205		<1%	3,207	$4K
87040		<1%	3,046	$4K
80074		<1%	464	$4K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,496	$4K
80055		<1%	146	$4K
83605		<1%	2,102	$4K
82728		<1%	3,203	$4K
82330		<1%	9,765	$4K
88342		<1%	950	$4K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	166	$4K
82950		<1%	1,317	$4K
12001		<1%	288	$4K
J1815	Injection, insulin, per 5 units	<1%	3,465	$4K
87510		<1%	5,338	$4K
J1170	Injection, hydromorphone, up to 4 mg	<1%	5,403	$4K
84156		<1%	1,715	$3K
82607		<1%	4,499	$3K
84481		<1%	694	$3K
71101		<1%	140	$3K
70491		<1%	14	$3K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	19,235	$3K
82105		<1%	920	$3K
87075		<1%	1,367	$3K
86901		<1%	4,700	$3K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	140	$3K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,143	$3K
87660		<1%	5,504	$3K
87640		<1%	819	$3K
87081		<1%	1,071	$3K
82274		<1%	401	$3K
80164		<1%	1,354	$3K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	125	$3K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	3,556	$3K
81001		<1%	5,363	$2K
90791	Psychiatric diagnostic evaluation	<1%	718	$2K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,205	$2K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	450	$2K
97161		<1%	49	$2K
72072		<1%	266	$2K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	90	$2K
93970		<1%	326	$2K
83690		<1%	11,900	$2K
85380		<1%	2,833	$2K
86308		<1%	195	$2K
90715		<1%	1,231	$2K
29125		<1%	591	$2K
0100U		<1%	102	$2K
84112		<1%	28	$2K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	3,139	$2K
86592		<1%	1,313	$1K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	3,447	$1K
83540		<1%	3,278	$1K
85004		<1%	1,061	$1K
84439		<1%	4,612	$1K
76830	Ultrasound, transvaginal	<1%	1,625	$1K
76770		<1%	61	$1K
83550		<1%	2,622	$1K
88341		<1%	173	$1K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	3,645	$1K
82077		<1%	628	$1K
73590		<1%	123	$1K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,983	$1K
73090		<1%	128	$1K
12011		<1%	153	$1K
77336		<1%	27	$1K
J2060	Injection, lorazepam, 2 mg	<1%	2,723	$1K
82043		<1%	2,531	$1K
82746		<1%	3,083	$1K
86762		<1%	995	$1K
82805		<1%	195	$979.32
P9016	Red blood cells, leukocytes reduced, each unit	<1%	27	$934.25
87340		<1%	2,514	$893.85
86038		<1%	291	$874.16
97535	Self-care/home management training, each 15 minutes	<1%	33	$839.04
73660		<1%	12	$814.94
83021		<1%	227	$802.22
82570		<1%	2,061	$792.63
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	4,250	$718.04
82248		<1%	1,516	$716.33
0352U		<1%	96	$701.63
84403		<1%	134	$695.75
84550		<1%	1,433	$693.65
10061		<1%	25	$641.52
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	199	$634.82
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	18	$614.48
87015		<1%	198	$605.27
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,593	$556.85
J3490	Unclassified drugs	<1%	1,026	$544.11
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	19	$528.63
94060		<1%	20	$510.14
84146		<1%	40	$507.23
86787		<1%	953	$492.97
J3475	Injection, magnesium sulfate, per 500 mg	<1%	287	$412.28
84480		<1%	181	$410.32
82550		<1%	1,785	$359.18
97167		<1%	26	$357.87
82140		<1%	717	$332.84
85014		<1%	702	$318.38
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	58	$316.15
36416		<1%	111	$305.49
88304		<1%	46	$290.58
85018		<1%	1,346	$261.15
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,542	$238.18
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	96	$238.05
86364		<1%	16	$231.62
12002		<1%	16	$176.93
83993		<1%	12	$154.32
86359		<1%	81	$145.69
82378		<1%	13	$132.55
87427		<1%	69	$131.52
87653		<1%	14	$125.49
83655		<1%	45	$116.57
84153		<1%	147	$115.08
80069		<1%	178	$114.98
73552		<1%	37	$114.71
86376		<1%	361	$111.43
87102		<1%	17	$98.68
87430		<1%	175	$98.55
87581		<1%	140	$95.78
87486		<1%	140	$95.78
82951		<1%	12	$87.62
83020		<1%	227	$72.47
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	263	$71.75
82785		<1%	48	$59.93
51798		<1%	78	$47.61
83615		<1%	546	$43.55
87536		<1%	78	$42.04
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	37	$38.10
86709		<1%	488	$37.12
87529		<1%	12	$35.32
84436		<1%	102	$31.75
82784		<1%	14	$29.27
84132		<1%	38	$27.95
86431		<1%	64	$19.69
86356		<1%	81	$19.38
86360		<1%	81	$19.38
85045		<1%	177	$18.97
86769		<1%	17	$17.67
80202		<1%	25	$17.10
83001		<1%	39	$16.44
83721		<1%	16	$15.54
80178		<1%	19	$7.95
83516		<1%	23	$6.61
87493		<1%	19	$6.42
81050		<1%	12	$5.32
87449		<1%	126	$4.23
82010		<1%	122	$3.31
86255		<1%	18	$3.30
85379		<1%	98	$2.63
86880		<1%	32	$1.27
J1940	Injection, furosemide, up to 20 mg	0%	14	$0.00
G0008	Administration of influenza virus vaccine	0%	74	$0.00
90686		0%	147	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	195	$0.00
0240U		0%	44	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	45	$0.00
87046		0%	67	$0.00
94761		0%	112	$0.00
82952		0%	12	$0.00
72170		0%	197	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	17	$0.00
J0561	Injection, penicillin g benzathine, 100,000 units	0%	26	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	59	$0.00
87481		0%	576	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	124	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	94	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	144	$0.00
J7510	Prednisolone oral, per 5 mg	0%	220	$0.00
87328		0%	13	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	15	$0.00
0353U		0%	121	$0.00
Q0244	Injection, casirivimab and imdevimab, 1200 mg	0%	27	$0.00
29515		0%	42	$0.00
85384		0%	22	$0.00
87400		0%	15	$0.00
87045		0%	67	$0.00
87329		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOGART, COLETTE (ACCOUNTING MANAGER)